Menu

About Musli Thyropeutics

Musli Thyropeutics is a pharmaceutical innovator addressing high-grade cancers. The company's scientists have developed a unique treatment based on recent scientific findings which deprives these aggressive cancers from a much needed hormone.

Musli is targeting Glioblastoma Multiforme as well as brain metastases from lung and other cancers and other aggressive high-grade cancers.

Musli is well poised to fulfil the unmet needs of several multi-billion dollar markets by providing an innovative adjunct approach to current standard of care.

Musli has a solid patent portfolio and worldwide exclusive marketing rights.

Musli has partnered with a leading manufacturer to secure high-quality GMP manufacturing.